Breast neoplasms Trials in Plantation, United States
Conditions / Breast neoplasms / Plantation, United States
Research into Breast neoplasms spans multiple therapeutic approaches and trial phases.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00191373 | A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease | COMPLETED | PHASE2 |
| NCT05514054 | A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | COMPLETED | PHASE2 |
| NCT00083993 | Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer | TERMINATED | PHASE3 |
| NCT00051051 | A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer | COMPLETED | PHASE2 |
| NCT04895358 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01945775 | A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) | COMPLETED | PHASE3 |
| NCT01740427 | A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2) | COMPLETED | PHASE3 |
| NCT06966453 | A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer | RECRUITING | — |
| NCT00043368 | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | COMPLETED | PHASE2 |